Figure 3From: KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice Tumor cell content. Estimated tumor cell content, after manual microdissection, in colorectal cancer tissues from 314 consecutive patient samples subjected to KRAS mutation analysis. Tumor cell content in wt samples (A) and in samples with a detected codon 12 or 13 KRAS mutation (B).Back to article page